CNH announces voting results of 2026 Annual General Meeting and publishes 2025 Sustainability ReportCNH announces voting results of 2026 Annual General Meeting and publishes 2025 Sustainability Report
Clarios Provides One Year Update on $6B U.S. Energy Manufacturing StrategyCompany highlights continued U.S. investment progress and advances in critical minerals recycling
New PatentVest Pulse Report Maps the Triple-Agonist Race and the Emerging Patent Battle Shaping the Post-GLP-1 Obesity Market· Analysis of 27 global triple-agonist programs highlights a rapidly expanding pipeline across major pharmaceutical companies and emerging biotech platforms.
BW Investors Have Opportunity to Lead Babcock & Wilcox Enterprises, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, May 08, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Babcock & Wilcox Enterprises, Inc. (“B&W” or “the Company”) (
NYSE: BW) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
GLOB Investors Have Opportunity to Lead Globant S.A. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, May 08, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Globant S.A. (“Globant” or “the Company”) (
NYSE: GLOB) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
STLA Investors Have Opportunity to Lead Stellantis N.V. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, May 08, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Stellantis N.V. (“Stellantis” or “the Company”) (
NYSE: STLA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
RGC Investors Have Opportunity to Lead Regencell Bioscience Holdings Limited Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, May 08, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Regencell Bioscience Holdings Limited (“Regencell” or “the Company”) (
NASDAQ: RGC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
LKQ Investors Have Opportunity to Lead LKQ Corporation Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, May 08, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against LKQ Corporation (“LKQ” or “the Company”) (
NASDAQ: LKQ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
UPST Investors Have Opportunity to Lead Upstart Holdings, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, May 08, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Upstart Holdings, Inc. (“Upstart” or “the Company”) (
NASDAQ: UPST) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
MEDP Investors Have Opportunity to Lead Medpace Holdings, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, May 08, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Medpace Holdings, Inc. (“Medpace” or “the Company”) (
NASDAQ: MEDP) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Inspire Named “Best Patient Experience Platform” in 10th Annual MedTech Breakthrough Awards ProgramLandmark 10th Annual Awards Program Recognizes the Most Innovative Digital Health and Medical Technology Solutions Worldwide
Gold Candle to Acquire Pan American Silver’s Larder Property, Further Enhancing Its Presence in the AbitibiAcquisition Adds Indicated Gold Resources of 388koz and Inferred Gold Resources of 933koz, and Grows Land Position to ~27,000 Hectares in the Abitibi
E-Power Granted Landmark Patent for Multi-Element Doped Hard Carbon Composites, Accelerating Sodium-Ion Battery CommercializationDOVER, USA, May 08, 2026 (GLOBE NEWSWIRE) -- E-Power Inc. (“E-Power”, the “Company”, “we” or “our”) (
NASDAQ: EPOW), a leading provider of AI Data Center (AIDC) microgrid solutions and advanced battery materials, today announced the successful patent grant and registration for its proprietary invention: "A Phosphorus-Silver-Silicon Co-Doped Hard Carbon Composite Material and Its Preparation Method" (Patent No: CN2023105784527).
Lamar Advertising to appear at the J.P. Morgan 2026 Global Technology, Media and Communications ConferenceBATON ROUGE, La., May 08, 2026 (GLOBE NEWSWIRE) -- Lamar Advertising Company (Nasdaq: LAMR) today announced that Sean Reilly, CEO of Lamar Advertising Company, is scheduled to participate in a question-and-answer session at the J.P. Morgan 2026 Global Technology, Media and Communications Conference on Monday, May 18, 2026 at approximately 3:30 pm EST.
GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, May 08, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Gossamer Bio, Inc. (“Gossamer” or “the Company”) (
NASDAQ: GOSS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Instead becomes the first new tax platform in decades to pass 100% government testing across all U.S. jurisdictions — replacing CCH, GoSystem, UltraTax, Lacerte, ProConnect, and Drake for the full tax stackSAN FRANCISCO, May 08, 2026 (GLOBE NEWSWIRE) -- Instead announced today it has completed government testing to electronically file and print tax returns across 100% of U.S. federal, state, and local jurisdictions. The milestone, which no new tax platform has achieved in decades, positions Instead as the only AI-native system with end-to-end authorization to handle research, planning, preparation, filing, and resolution in a single platform.
PINS Investors Have Opportunity to Lead Pinterest, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, May 08, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Pinterest, Inc. (“Pinterest” or “the Company”) (
NYSE: PINS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Sherwin-Williams Increases Freight Utilization by 11% with Retail Store Delivery Solution by ITS Logistics-- Partnership proves private fleets can improve utilization, protect brand standards, and scale for peak demand with strategic purchased transportation solutions. --
VITL Investors Have Opportunity to Lead Vital Farms, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, May 08, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Vital Farms, Inc. (“Vital Farms” or “the Company”) (
NASDAQ: VITL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Lowey Dannenberg, P.C. is Investigating Fulgent Genetics Inc. (NASDAQ: FLGT) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the FirmNEW YORK, May 08, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (
NASDAQ: FLGT) for potential violations of the federal securities laws.
Lowey Dannenberg, P.C. is Investigating ADMA Biologics (NASDAQ: ADMA) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the FirmNEW YORK, May 08, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating ADMA Biologics (
NASDAQ: ADMA) (“ADMA Biologics” or the “Company”) for potential violations of the federal securities laws.
Hub Group (NASDAQ: HUBG) Investigated for Potential Federal Securities Laws Violations – Lowey Dannenberg, P.C.NEW YORK, May 08, 2026 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a top complex litigation law firm, is investigating Hub Group Inc. (
NASDAQ: HUBG) (“Hub Group” or the “Company”) for potential violations of the federal securities laws.
ALDX Investors Have Opportunity to Lead Aldeyra Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, May 08, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Aldeyra Therapeutics, Inc. (“Aldeyra” or “the Company”) (
NASDAQ: ALDX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
COTY Investors Have Opportunity to Lead Coty Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, May 08, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Coty Inc. (“Coty” or “the Company”) (
NYSE: COTY) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
ATRA Investors Have Opportunity to Lead Atara Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, May 08, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Atara Biotherapeutics, Inc. (“Atara” or “the Company”) (
NASDAQ: ATRA) violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Sono Group N.V. Completes Exit from Legacy Solar OperationsTransfer of Sono Motors to Its Management Team Marks Full Completion of the Strategic Transition Announced in March 2026; Sono Group Currently Operates as a Focused Digital Asset Treasury Company
IP Strategy Highlights Poseidon’s Launch of Numo, Expanding Supply of Rights-Cleared AI Training Data on StoryGIG HARBOR, Wash., May 08, 2026 (GLOBE NEWSWIRE) -- IP Strategy Holdings, Inc. (Nasdaq: IPST) (the “Company” or “IP Strategy”) today highlighted the early access launch of Numo, a consumer application developed by Poseidon designed to scale the collection of real-world, rights-cleared training data for AI systems.
Alpha Tau Completes Patient Enrollment in its U.S. Pivotal Skin Cancer Study, Advancing Towards Goal of FDA Approval of Alpha DaRT® to Treat Recurrent Cutaneous Squamous Cell Carcinoma- First U.S. pivotal study for Alpha Tau to have completed enrollment, representing a critical milestone on the path towards potential FDA pre-market approval (PMA); Company has already initiated PMA modular application process -
NUMERATOR CONSUMER GOODS PRICE INDEX REVEALS PRICES FOR EVERYDAY GOODS UP 2.4% IN APRIL VS. YEAR AGOInflation Reaccelerated in April; Gen Z Hit Hardest, Absorbing 6-Point Higher Price Growth vs. U.S. Average Since January 2018
XRP POWER Launches AI-Driven Trading Model, Reshaping Intelligent Investment ManagementXRP POWER today officially launched its next-generation AI-driven intelligent trading workspace, designed to provide users with a unified quantitative environment that integrates strategy research, market analysis, and portfolio management, driving the trading process towards a more systematic and structured direction.
Verizon to Speak at Upcoming Investor ConferencesNEW YORK, May 08, 2026 (GLOBE NEWSWIRE) -- Dan Schulman, CEO of Verizon (NYSE, Nasdaq: VZ), is scheduled to speak at the MoffettNathanson Media, Internet & Communications Conference on Wednesday, May 13, at 9:00 a.m. ET.
E-Power Awarded Government Grant to Accelerate Innovation about Carbon-Based Anode MaterialDOVER, USA, May 08, 2026 (GLOBE NEWSWIRE) -- E-Power Inc. (“E-Power”, the “Company”, “we” or “our”) (
NASDAQ: EPOW), a leading provider of AI Data Center (AIDC) microgrid solutions and advanced battery materials, is pleased to announce that its subsidiary, Sunrise (Guizhou) New Energy Materials Co., Ltd. ("Sunrise New Energy"), has been selected as a recipient of the 2026 provincial budget for capital construction investment. The Guizhou Provincial Development and Reform Commission officially issued the notice for the first batch of investment plans, awarding a $294,000 special fund to support the "Guizhou Carbon-Based Anode Material Industrial Technology Engineering Center Innovation Capability Construction Project".
MoneyFlare Launches AI Trading Bot to Help Investors Capture Bitcoin, Dogecoin, and Stock Market OpportunitiesUse a beginner-friendly AI Trading Bot to participate in Bitcoin, Dogecoin, and stock markets through AI algorithms, quantitative trading models, and a fully managed automated execution system designed to capture crypto and stock trading opportunities around the clock.
CloudBolt Advances Its Cloud Management Platform With AI-Ready Control, Finer-Grained Governance, and Expanded Support for VMware AlternativesNew CMP release introduces MCP support, more contextual role-based access, custom day-two actions, and expanded resource handlers for organizations diversifying hybrid cloud and virtualization strategies
BioAge Labs Reports First Quarter 2026 Financial Results and Provides Business UpdatesPositive topline Phase 1 data for BGE-102, demonstrating potential best-in-class reductions among oral NLRP3 inhibitors in inflammatory biomarkers of cardiovascular risk
Randian Capital publishes Open Letter to Snap Board, calling for the Snap Board to consider evaluating strategic alternativesNEW YORK, May 08, 2026 (GLOBE NEWSWIRE) -- Randian Capital, a retail activist investment firm, and a shareholder of Snap Inc. publishes Open Letter to Snap Board, calling for the Snap Board to consider evaluating strategic alternatives for the company.
AIM ImmunoTech, Inc. Announces Exercise of Warrants for Approx. $4.2 Million in Gross ProceedsOCALA, Fla., May 08, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech, Inc. (NYSEAM:AIM) (“AIM ImmunoTech” or the “Company”), a late-stage biotechnology company focused on the discovery and development of drugs for the treatment of cancer, today announced an agreement between the Company and certain accredited investors to exercise certain outstanding Class A, Class B, Class C, Class D, Class E and Class F Warrants (the “Existing Warrants”) to purchase up to an aggregate of 8,719,928 shares of common stock at a reduced exercise price of $0.48 per share for gross proceeds of approximately $4.2 million, before deducting placement agent fees and other estimated offering expenses. The Company intends to use the net proceeds from the offering for working capital and general corporate purposes.
CG Oncology Reports First Quarter 2026 Financial Results and Provides Business UpdatesDALLAS, May 08, 2026 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (
NASDAQ: CGON) today reported financial results for the first quarter ended March 31, 2026, and provided business updates.
Prenetics to Report Q1 2026 Financial Results on May 14, 2026 and Host Earnings Conference CallNEW YORK, May 08, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (
NASDAQ: PRE) ("Prenetics" or the "Company"), the parent company of IM8, the premium health and longevity brand co-founded with David Beckham, today announced it will release financial results for the first quarter 2026 ended March 31, 2026 before market open on Thursday, May 14, 2026. The Company will also hold its earnings conference call the same day at 10:00 a.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with analysts.
NetworkNews Audio Announces Audio Press Release (APR) Discussing Service Robotics Industry Transition from Conceptual Innovation to Practical DeploymentAUSTIN, Texas, May 08, 2026 (GLOBE NEWSWIRE) -- via IBN – NetworkNewsAudio announces the Audio Press Release (APR) titled “Service Robotics Growth Accelerates as Global Demand Fuels Strategic Expansion,” featuring Nightfood Holdings Inc. (NGTF).
Stran & Company Schedules First Quarter 2026 Financial Results and Business Update Conference CallQuincy, MA, May 08, 2026 (GLOBE NEWSWIRE) -- Stran & Company, Inc. ("Stran" or the "Company") (
NASDAQ: SWAG) (
NASDAQ: SWAGW), a leading outsourced marketing solutions provider that leverages its promotional products and loyalty incentive expertise, today announced that it will host a conference call at 10:00 A.M. Eastern Time on Wednesday, May 13, 2026, to discuss the Company’s financial results for the first quarter of 2026 ended March 31, 2026, as well as the Company’s corporate progress and other developments.
InflaRx Announces Closing of $150 Million Underwritten Offering of Ordinary SharesJena, Germany, May 08, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX) (the “Company”), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, announced today that it has completed its underwritten offering of 75,000,000 ordinary shares of the Company at an offering price of $2.00 per ordinary share. The aggregate gross proceeds from the offering were $150 million, before deducting the underwriting discount and offering expenses.
ALX Oncology Reports First Quarter 2026 Financial Results and Provides Corporate Update- Data from Phase 1b/2 trial of evorpacept + zanidatamab presented at ESMO Breast Cancer 2026 showed all patients with confirmed HER2-positive disease and high CD47 expression experienced durable responses to this combination -
Kratos Names Odon, Indiana as Home of New Hypersonic Test FacilityOnce Complete, Kratos’ Arc Jet and Laser Facility’s Multi-Domain Test Capability is Expected to Accelerate Hypersonic Materials Development for Decades, Advancing U.S. Defense Infrastructure
Alamar Biosciences Reports First Quarter 2026 Financial ResultsFREMONT, Calif., May 08, 2026 (GLOBE NEWSWIRE) -- Alamar Biosciences, Inc. (Nasdaq: ALMR), a leader in Precision Proteomics dedicated to enabling the earliest detection of disease, today reported financial results for the quarter ended March 31, 2026.
State of New York Offers Bell 430 Helicopter Through Online Auction on GovDealsThe aircraft will still be used in service by the state until the completion of the sale
WRAP® to Showcase Non-Lethal Response™ Platform at European Law Enforcement Conference in Italy for Public Safety ProfessionalsEvents plan to highlight BolaWrap®, WrapReality™, and WRAP’s integrated approach to tools, training, and policy for modern public safety, leading with compliance through sight, sound, and then sensation
Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)BRISBANE, Calif., May 08, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced the granting of inducement awards on May 4, 2026 to ten new employees under Pacira’s Amended and Restated 2014 Inducement Plan (the “Inducement Plan”) as a material inducement to each employee’s entry into employment with the company. In accordance with Nasdaq Listing Rule 5635(c)(4), the awards were approved by the People & Compensation Committee of the Board of Directors (the “Committee”) without stockholder approval.
Acres.com Launches Acres Intelligence, the First AI Agent Built for Land TeamsFayetteville, Ark., May 08, 2026 (GLOBE NEWSWIRE) -- Acres.com, the complete AI land intelligence platform, today announced the launch of Acres Intelligence, the first AI agent designed to work alongside land acquisition and development teams, to research new sites, analyze constraints, and produce professional-grade reports and dashboards in minutes, all within the platform.
CCH Holdings Announces the Redesignation of its Ordinary Share as Class A Ordinary SharesBUKIT MERTAJAM, MALAYSIA, May 08, 2026 (GLOBE NEWSWIRE) -- CCH Holdings Ltd (Nasdaq: CCHH) (“CCH” or the “Company”), a Malaysia-based specialty hotpot restaurant chain, today announced that all conditions to the implementation of its dual-class share structure and redesignation of ordinary shares as Class A ordinary shares have been satisfied and that its dual-class share structure is effective on the Nasdaq Capital Market following the results of the Annual General Meeting on March 4, 2026.
EAIGG Announces Global Expansion Anchored in Europe; Anna Fellander Joins Leadership with Founding PartnershipsSTOCKHOLM, May 08, 2026 (GLOBE NEWSWIRE) -- The Ethical AI Governance Group (EAIGG) today announced a major global expansion, anchored by the launch of its European platform, the appointment of new regional leadership, and the formation of founding partnerships across industry and academia.
Altus Group Strengthens its Canadian Leadership PresenceTORONTO, May 08, 2026 (GLOBE NEWSWIRE) -- Altus Group Limited (ʺAltus Group”, “Altus” or “the Company”) (TSX: AIF), a leading provider of commercial real estate (“CRE”) intelligence, today announced key appointments to its Canadian leadership in support of the Company’s long-term growth strategy in the Canadian market.
Abaxx Exchange Named Newcomer of the Year at 2026 Energy Risk AwardsRecognition follows the introduction of 16 commodity futures benchmarks and growing activity across Abaxx Exchange markets
Traws Pharma to Advance Potential Clinical Candidates for the Treatment of Hantavirus InfectionsNEWTOWN, Pa., May 08, 2026 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (
NASDAQ: TRAW) (“Traws Pharma”, “Traws” or “the Company”), a clinical-stage biopharmaceutical company developing novel therapies to target critical threats to human health from respiratory viral diseases, today announced plans to advance potential clinical candidates for the treatment of hantavirus infections.
Exodus Launches XO Cash as the First Stablecoin Built for AI AgentsLive today at XOCash.com, XO Cash is a stablecoin for AI agents; its SDK lets users grant any agent its own wallet, funded from their Exodus Pay balance, while keeping the keys
Treace Medical Concepts Reports First Quarter 2026 Financial ResultsPONTE VEDRA, Fla., May 08, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today reported financial results for the first quarter ended March 31, 2026.
BsStrategy Officially Launches AI Quantitative Trading Bot to Streamline Automated Market ExecutionThe platform connects AI market analysis, quantitative strategy selection, bot-assisted execution, and activity tracking in one trading environment.
illumin Reports First Quarter 2026 Financial ResultsFirst Quarter Revenue Reaches $35.0 MillionExchange Service Revenue Up 45% YoYManaged Service Revenue Up 7% YoY
TeraWulf Reports First Quarter 2026 ResultsDevelopment timeline on track at WULF Compute
AMC Global Media Inc. Reports First Quarter 2026 ResultsNEW YORK, May 08, 2026 (GLOBE NEWSWIRE) -- AMC Global Media Inc. ("AMC Global Media" or the "Company") (
NASDAQ: AMCX) today reported financial results for the first quarter ended March 31, 2026.
GigaCloud Technology Inc to Participate in 21st Annual Needham Technology, Media, & Consumer ConferenceEL MONTE, Calif., May 08, 2026 (GLOBE NEWSWIRE) -- GigaCloud Technology Inc (Nasdaq: GCT) (“GigaCloud” or the “Company”), a pioneer of global end-to-end B2B ecommerce technology solutions for large parcel merchandise, today announced that Larry Wu, its Founder and Chief Executive Officer, will present at the 21st Annual Needham Technology, Media, & Consumer Conference on Thursday, May 14, 2026, at 2:15 p.m. ET/11:15 a.m. PT.
Hyperion DeFi Announces Closing of Public Offering of Common StockDALLAS, May 08, 2026 (GLOBE NEWSWIRE) -- Hyperion DeFi, Inc. (
NASDAQ: HYPD) (“Hyperion DeFi” or the “Company”), the first U.S. publicly listed DeFi company building on Hyperliquid, today announced that it has closed its previously announced public offering of 2,777,778 shares of its common stock. The shares of common stock were sold to the public at a price of $3.60 per share. All of the shares of common stock sold in the public offering were sold by Hyperion DeFi. The gross proceeds to Hyperion DeFi from the offering, before deducting the underwriting discounts and commissions and other offering expenses, were approximately $10.0 million. Hyperion DeFi has also granted the sole underwriter a 30-day option to purchase up to an additional 416,666 shares of its common stock at the public offering price per share, less underwriting discounts and commissions.
MapLight Therapeutics to Participate in Upcoming Investor ConferencesSAN FRANCISCO and BOSTON, May 08, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (Nasdaq: MPLT) today announced that members of its management team will participate in the following investor conferences:
First Advantage to Participate in Upcoming Investor ConferencesATLANTA, May 08, 2026 (GLOBE NEWSWIRE) -- First Advantage Corporation (
NASDAQ: FA), a global software and data company, today announced the Company’s management team will participate in the following upcoming investor conferences:
Artiva Biotherapeutics Announces Pricing of $300 Million Underwritten Offering of Common Stock and Pre-Funded WarrantsSAN DIEGO, May 08, 2026 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV) (Artiva), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients with debilitating autoimmune diseases, today announced the pricing of an underwritten offering of 23,871,526 shares of its common stock at a price of $11.52 per share and, in lieu of shares of common stock to certain investors, pre-funded warrants to purchase 2,170,138 shares of common stock at a purchase price of $11.5199 per share, which equals the offering price per share of the common stock less the $0.0001 exercise price per share of each pre-funded warrant. All the shares of common stock and pre-funded warrants in the offering are being sold by Artiva.
